Statistical Analysis of Prevalence, Incidence, Comorbidities and Medical Expense in Epileptic Children in Taiwan Based on National Health Research Insurance Database.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

169026 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-03-09

Study Completion Date

2021-02-19

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Epilepsy is a common disease in pediatric neurology. In recent years, due to the promotion of Taiwan's health insurance and the advancement of related medical treatments and anti-epileptic drugs, the prevalence, incidence, and related comorbidities of childhood epilepsy in Taiwan are expected, as well as the number of epilepsy patients in different regions or different age groups. and medical costs may change. This study aims to collect data from the National Health Insurance Database through the National Institutes of Health, review relevant data on childhood epilepsy patients from 2001 to 2013, and analyze trends to discuss the impact of universal health insurance and medical progress on childhood epilepsy patients. Impact.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Sleep Intervention for Pediatric Epilepsy

NCT02514291

Epilepsy

COMPLETED NA

Emotion/Behavior Problems, Neuropsychological Functioning, and Parental Adjustment in Children With Epilepsy

NCT00550940

Epilepsy

COMPLETED

Clinic-based and Technology-Supported Sleep Intervention for Pediatric Epilepsy

NCT06661759

Epilepsy

RECRUITING NA

Big Data Construction and Biological Etiological Epidemiology Study of Children Epilepsy in China

NCT02969213

Epilepsy

UNKNOWN

Nucleotide Protein -3 in Epileptic Children

NCT04219930

Epilepsy in Children

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neurologic Disorder Seizure Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

seizure

epileptic children

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Targets aged 0\~19 (\<=19) in the home country
2. Diagnosis code includes ICD9: 345.XX, ACODE:A225 (including outpatient and inpatient)
3. Between 2001 and 2013, those who had seen a doctor three times in a row with epilepsy diagnosis codes and used anti-epileptic drugs

Exclusion Criteria

* Exclude those who sought medical treatment for epilepsy from 2001 to 2013, but the number of medical visits (outpatient + hospitalization) \<3 times, and exclude those who did not take medication from 2001 to 2013.

Minimum Eligible Age

0 Years

Maximum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No